Literature DB >> 24699327

Colonic inflammation and secondary bile acids in alcoholic cirrhosis.

Genta Kakiyama1, Phillip B Hylemon2, Huiping Zhou3, William M Pandak1, Douglas M Heuman1, Dae Joong Kang1, Hajime Takei4, Hiroshi Nittono4, Jason M Ridlon2, Michael Fuchs1, Emily C Gurley2, Yun Wang3, Runping Liu3, Arun J Sanyal1, Patrick M Gillevet5, Jasmohan S Bajaj6.   

Abstract

Alcohol abuse with/without cirrhosis is associated with an impaired gut barrier and inflammation. Gut microbiota can transform primary bile acids (BA) to secondary BAs, which can adversely impact the gut barrier. The purpose of this study was to define the effect of active alcohol intake on fecal BA levels and ileal and colonic inflammation in cirrhosis. Five age-matched groups {two noncirrhotic (control and drinkers) and three cirrhotic [nondrinkers/nonalcoholics (NAlc), abstinent alcoholic for >3 mo (AbsAlc), currently drinking (CurrAlc)]} were included. Fecal and serum BA analysis, serum endotoxin, and stool microbiota using pyrosequencing were performed. A subgroup of controls, NAlc, and CurrAlc underwent ileal and sigmoid colonic biopsies on which mRNA expression of TNF-α, IL-1β, IL-6, and cyclooxygenase-2 (Cox-2) were performed. One hundred three patients (19 healthy, 6 noncirrhotic drinkers, 10 CurrAlc, 38 AbsAlc, and 30 NAlc, age 56 yr, median MELD: 10.5) were included. Five each of healthy, CurrAlc, and NAlc underwent ileal/colonic biopsies. Endotoxin, serum-conjugated DCA and stool total BAs, and secondary-to-primary BA ratios were highest in current drinkers. On biopsies, a significantly higher mRNA expression of TNF-α, IL-1β, IL-6, and Cox-2 in colon but not ileum was seen in CurrAlc compared with NAlc and controls. Active alcohol use in cirrhosis is associated with a significant increase in the secondary BA formation compared with abstinent alcoholic cirrhotics and nonalcoholic cirrhotics. This increase in secondary BAs is associated with a significant increase in expression of inflammatory cytokines in colonic mucosa but not ileal mucosa, which may contribute to alcohol-induced gut barrier injury.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  alcohol; cytokines; farnesoid X receptor; microbiome

Mesh:

Substances:

Year:  2014        PMID: 24699327      PMCID: PMC4152166          DOI: 10.1152/ajpgi.00315.2013

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  39 in total

1.  Large intestine permeability is increased in patients with compensated liver cirrhosis.

Authors:  Kirsten E Pijls; Ger H Koek; Elhaseen E Elamin; Hanne de Vries; Ad A M Masclee; Daisy M A E Jonkers
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-11-21       Impact factor: 4.052

Review 2.  Inflammation and colorectal cancer: colitis-associated neoplasia.

Authors:  Sergei I Grivennikov
Journal:  Semin Immunopathol       Date:  2012-11-16       Impact factor: 9.623

3.  Dietary fat sources differentially modulate intestinal barrier and hepatic inflammation in alcohol-induced liver injury in rats.

Authors:  Wei Zhong; Qiong Li; Guoxiang Xie; Xiuhua Sun; Xiaobing Tan; Xinguo Sun; Wei Jia; Zhanxiang Zhou
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-10-10       Impact factor: 4.052

Review 4.  Bile acids in the colon, from healthy to cytotoxic molecules.

Authors:  Juan I Barrasa; Nieves Olmo; Ma Antonia Lizarbe; Javier Turnay
Journal:  Toxicol In Vitro       Date:  2012-12-27       Impact factor: 3.500

5.  Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption.

Authors:  Guoxiang Xie; Wei Zhong; Houkai Li; Qiong Li; Yunping Qiu; Xiaojiao Zheng; Huiyuan Chen; Xueqing Zhao; Shucha Zhang; Zhanxiang Zhou; Steven H Zeisel; Wei Jia
Journal:  FASEB J       Date:  2013-05-24       Impact factor: 5.191

6.  Modulation of the fecal bile acid profile by gut microbiota in cirrhosis.

Authors:  Genta Kakiyama; William M Pandak; Patrick M Gillevet; Phillip B Hylemon; Douglas M Heuman; Kalyani Daita; Hajime Takei; Akina Muto; Hiroshi Nittono; Jason M Ridlon; Melanie B White; Nicole A Noble; Pamela Monteith; Michael Fuchs; Leroy R Thacker; Masoumeh Sikaroodi; Jasmohan S Bajaj
Journal:  J Hepatol       Date:  2013-01-16       Impact factor: 25.083

7.  Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.

Authors:  Sama I Sayin; Annika Wahlström; Jenny Felin; Sirkku Jäntti; Hanns-Ulrich Marschall; Krister Bamberg; Bo Angelin; Tuulia Hyötyläinen; Matej Orešič; Fredrik Bäckhed
Journal:  Cell Metab       Date:  2013-02-05       Impact factor: 27.287

8.  Altered profile of human gut microbiome is associated with cirrhosis and its complications.

Authors:  Jasmohan S Bajaj; Douglas M Heuman; Phillip B Hylemon; Arun J Sanyal; Melanie B White; Pamela Monteith; Nicole A Noble; Ariel B Unser; Kalyani Daita; Andmorgan R Fisher; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  J Hepatol       Date:  2013-12-25       Impact factor: 25.083

9.  Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship.

Authors:  Jason M Ridlon; Joao Marcelo Alves; Phillip B Hylemon; Jasmohan S Bajaj
Journal:  Gut Microbes       Date:  2013-07-12

10.  Hepatic cannabinoid receptor type 1 mediates alcohol-induced regulation of bile acid enzyme genes expression via CREBH.

Authors:  Dipanjan Chanda; Yong-Hoon Kim; Tiangang Li; Jagannath Misra; Don-Kyu Kim; Jung Ran Kim; Joseph Kwon; Won-Il Jeong; Sung-Hoon Ahn; Tae-Sik Park; Seung-Hoi Koo; John Y L Chiang; Chul-Ho Lee; Hueng-Sik Choi
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

View more
  71 in total

Review 1.  Alcoholic liver disease: the gut microbiome and liver cross talk.

Authors:  Phillipp Hartmann; Caroline T Seebauer; Bernd Schnabl
Journal:  Alcohol Clin Exp Res       Date:  2015-05       Impact factor: 3.455

2.  The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis.

Authors:  Puneet Puri; Suthat Liangpunsakul; Jeffrey E Christensen; Vijay H Shah; Patrick S Kamath; Gregory J Gores; Susan Walker; Megan Comerford; Barry Katz; Andrew Borst; Qigui Yu; Divya P Kumar; Faridoddin Mirshahi; Svetlana Radaeva; Naga P Chalasani; David W Crabb; Arun J Sanyal
Journal:  Hepatology       Date:  2018-02-22       Impact factor: 17.425

Review 3.  Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy.

Authors:  John Y L Chiang; Jessica M Ferrell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-27       Impact factor: 4.052

4.  Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis.

Authors:  Katharina Brandl; Phillipp Hartmann; Lily J Jih; Donald P Pizzo; Josepmaria Argemi; Meritxell Ventura-Cots; Sally Coulter; Christopher Liddle; Lei Ling; Stephen J Rossi; Alex M DePaoli; Rohit Loomba; Wajahat Z Mehal; Derrick E Fouts; Michael R Lucey; Francisco Bosques-Padilla; Philippe Mathurin; Alexander Louvet; Guadalupe Garcia-Tsao; Elizabeth C Verna; Juan G Abraldes; Robert S Brown; Victor Vargas; Jose Altamirano; Juan Caballería; Debbie Shawcross; Peter Stärkel; Samuel B Ho; Ramon Bataller; Bernd Schnabl
Journal:  J Hepatol       Date:  2018-04-12       Impact factor: 25.083

5.  Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut.

Authors:  Jason M Ridlon; Dae-Joong Kang; Phillip B Hylemon; Jasmohan S Bajaj
Journal:  Dig Dis       Date:  2015-05-27       Impact factor: 2.404

6.  The 'in vivo lifestyle' of bile acid 7α-dehydroxylating bacteria: comparative genomics, metatranscriptomic, and bile acid metabolomics analysis of a defined microbial community in gnotobiotic mice.

Authors:  Jason M Ridlon; Saravanan Devendran; João Mp Alves; Heidi Doden; Patricia G Wolf; Gabriel V Pereira; Lindsey Ly; Alyssa Volland; Hajime Takei; Hiroshi Nittono; Tsuyoshi Murai; Takao Kurosawa; George E Chlipala; Stefan J Green; Alvaro G Hernandez; Christopher J Fields; Christy L Wright; Genta Kakiyama; Isaac Cann; Purna Kashyap; Vance McCracken; H Rex Gaskins
Journal:  Gut Microbes       Date:  2019-06-09

Review 7.  Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know?

Authors:  Lu Jiang; Bernd Schnabl
Journal:  Physiology (Bethesda)       Date:  2020-07-01

Review 8.  Gut microbiome changes in Nonalcoholic fatty liver disease & alcoholic liver disease.

Authors:  Eric K Kwong; Puneet Puri
Journal:  Transl Gastroenterol Hepatol       Date:  2021-01-05

9.  Bile Acid 7α-Dehydroxylating Gut Bacteria Secrete Antibiotics that Inhibit Clostridium difficile: Role of Secondary Bile Acids.

Authors:  Jason D Kang; Christopher J Myers; Spencer C Harris; Genta Kakiyama; In-Kyoung Lee; Bong-Sik Yun; Keiichi Matsuzaki; Megumi Furukawa; Hae-Ki Min; Jasmohan S Bajaj; Huiping Zhou; Phillip B Hylemon
Journal:  Cell Chem Biol       Date:  2018-10-25       Impact factor: 8.116

Review 10.  Implications of microbiota and bile acid in liver injury and regeneration.

Authors:  Hui-Xin Liu; Ryan Keane; Lili Sheng; Yu-Jui Yvonne Wan
Journal:  J Hepatol       Date:  2015-08-07       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.